The Agglomeration Tendency of Low-molecular-weight Poly(N-isopropylacrylamide)

Agglomeration Tendency in Dry Pharmaceutical Granular Systems During Blending: De-Agglomeration Modeling Approaches

Efficient blending of powders is of critical importance in the manufacture of a wide variety of industrial products, including pharmaceuticals, foods, plastics and agrochemicals [1, 2]. This study determined the influence of geometry of blenders (double cone blender and V-blender), blending speed and time. The blend composed of diclofenac sodium, lactose, magnesium stearate and talc. It was sub...

Low Molecular Weight Heparin Overdose: A 10 Year Case Series

  Background: Low molecular weight heparin (LMWH) is used for the treatment and prevention of coagulative disorders. Few patients receiving therapeutic doses of LMWH develop major hemorrhage. Currently there are few reports in the literature on acute overdose on adults.  In this study, clinical profile, treatment and outcome of 21 patients who acutely overdosed enoxaparin are described. Method...

Low molecular weight heparin.

Low Molecular Weight Micelles

I.F. Uchegbu et al. (eds.), Fundamentals of Pharmaceutical Nanoscience, DOI 10.1007/978-1-4614-9164-4_2, © Springer Science+Business Media New York 2013 Abstract Low molecular weight amphiphile micelles are formed from the selfassembly of comparatively hydrophilic amphiphiles (molecular weight <1,500 Da). These structures may be spherical or present as nanofi bres in the case of peptide amphiph...

Differentiation of the low-molecular-weight heparins.

The three low-molecular-weight heparins (LMWHs) available in the United States have been extensively evaluated for a wide array of indications. Properties associated with one LMWH cannot be assumed to be the same as those associated with another LMWH, as they are different pharmacologic entities. Therefore, therapeutic interchange of these agents is inappropriate. The pharmacokinetic and pharma...